Posaconazole in the Prevention of COVID-19-associated Mucormycosis: A Concerning Contributor to the Rise in Antifungal Resistance.

Kayarat, Bhavana; Khanna, Puneet

Kayarat, Bhavana; Khanna, Puneet.

Kayarat B; Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India.
Khanna P; Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India.

Indian J Crit Care Med ; 25(10): 1209-1210, 2021 Oct.

Article in English | MEDLINE | ID: covidwho-1468639

ABSTRACT

ABSTRACT

How to cite this article Kayarat B, Khanna P. Posaconazole in the Prevention of COVID-19-associated Mucormycosis A Concerning Contributor to the Rise in Antifungal Resistance. Indian J Crit Care Med 2021;25(10)1209-1210.

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Indian J Crit Care Med Year: 2021 Document Type: Article Affiliation country: Jp-journals-10071-23981

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google